CRIS FY 2021 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M-1.7% YoY

Gross Profit

$10M95.0% margin

Operating Income

-$42M-395.0% margin

Net Income

-$45M-426.7% margin

EPS (Diluted)

$-9.92

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$162M

Total Liabilities

$72M

Stockholders' Equity

$91M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$11M	-1.7%
Gross Profit	$10M	$10M	-1.8%
Operating Income	-$42M	-$25M	-68.9%
Net Income	-$45M	-$30M	-51.9%